The Hyderabad based Divis Laboratories has received a letter of approval from Ministry of Commerce, Government of India, for setting up and development of a sector specific Special Economic Zone (SEZ) for pharmaceuticals ingredients at Chippada, Bheemunipatnam in Andhra Pradesh. The details of land have also been notified in the Gezette of India, Extraordinary on May 16, 2006.
Divis' has major interests in the areas of generics, intermediates, protected amino acids, chiral synthesis and carotenoids. Divis undertakes custom manufacture of APIs and production of advanced Intermediates to its clients over the entire life cycle of the products.
Divi's also undertakes FTE/Contract Research on process development for discovering new compounds for leading MNCs across the world and partners with them for the supply of APIs.